Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?"

Outeiro, Tiago F; Krisko, Anita

Outeiro, Tiago F; Krisko, Anita.

Outeiro TF; Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center Goettingen, Goettingen, Germany.
Krisko A; Max Planck Institute for Experimental Medicine, Goettingen, Germany.

Mov Disord ; 36(2): 278-279, 2021 02.

Article in English | MEDLINE | ID: covidwho-1086499

Subject(s)

COVID-19; Parkinson Disease; Aging; Humans; SARS-CoV-2

Keywords

COVID-19; Parkinson's disease; aging; SARS-CoV-2; neurodegenerative disease

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / COVID-19 Limits: Humans Language: English Journal: Mov Disord Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: Mds.28482

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google